Brief: VolitionRx limited announces third quarter results
09/11/2017 21:05
Nov 9 (Reuters) - Volitionrx Ltd VNRX.A
* VolitionRx Limited announces third quarter 2017 financial
results and business update
* Q3 loss per share $0.15
* Q3 earnings per share view $-0.15 -- Thomson Reuters
I/B/E/S
Source text for Eikon: ID:nPn6NJ1gBa
Further company coverage: VNRX.A
((Bangalore.newsroom@thomsonreuters.com;;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems